Dr. Taivanbaatar Erdenebileg

• Approximately 20 years in the medical field, specializing in general surgery and hepatobiliary-pancreatic conditions.

• National Cancer Center of Mongolia: Department of Hepatobiliary and Pancreatic Surgery (present)

• Intermed Hospital, Ulaanbaatar, Mongolia: Consultant in Hepatobiliary and Pancreatic Surgery (present)

• Mongolian National University of Medical Sciences: Clinical Professor in Oncology (present)

Dr. Erdenebileg has co-authored several significant research publications, including:

• "Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents"
  Published in Clinical Cancer Research in 2022, this study investigates the unique molecular characteristics of hepatocellular carcinoma in Mongolia.

• "Comparison of Clinical Features of Hepatitis B and C Virus-Related Hepatocellular Carcinoma"
  Published in the Central Asian Journal of Medical Sciences in 2022, this study compares the clinical characteristics of hepatocellular carcinoma related to hepatitis B and C viruses.

Dr. Taivanbaatar Erdenebileg is a distinguished Mongolian hepatobiliary and pancreatic surgeon with over 20 years of clinical experience. He is affiliated with Intermed Hospital in Ulaanbaatar, Mongolia, where he serves as a consultant in hepatobiliary and pancreatic surgery. Additionally, he holds the position of Clinical Professor in Oncology at the Mongolian National University of Medical Sciences.